ADENOSCAN

Adenoscan Adverse Events Reported to the FDA Over Time

How are Adenoscan adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Adenoscan, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Adenoscan is flagged as the suspect drug causing the adverse event.

Most Common Adenoscan Adverse Events Reported to the FDA

What are the most common Adenoscan adverse events reported to the FDA?

Dyspnoea	48 (4.74%)
Chest Pain	29 (2.87%)
Blood Pressure Decreased	22 (2.17%)
Respiratory Arrest	20 (1.98%)
Tremor	20 (1.98%)
Nausea	18 (1.78%)
Cardiac Arrest	17 (1.68%)
Body Temperature Increased	16 (1.58%)
Infusion Related Reaction	16 (1.58%)
Bronchospasm	15 (1.48%)
Atrioventricular Block Complete	14 (1.38%)
	Show More
Chills	14 (1.38%)
Headache	14 (1.38%)
Dizziness	13 (1.28%)
Loss Of Consciousness	13 (1.28%)
Vomiting	13 (1.28%)
Atrioventricular Block	12 (1.19%)
Blood Pressure Increased	12 (1.19%)
Cardio-respiratory Arrest	12 (1.19%)
Coronary Artery Disease	12 (1.19%)
Diarrhoea	12 (1.19%)
Hypotension	12 (1.19%)
Arteriospasm Coronary	11 (1.09%)
Oxygen Saturation Decreased	11 (1.09%)
Atrioventricular Block Second Degre...	10 (.99%)
Pyrexia	10 (.99%)
Chest Discomfort	9 (.89%)
Procedural Complication	9 (.89%)
Pulmonary Oedema	9 (.89%)
Convulsion	8 (.79%)
Hypertension	8 (.79%)
Pain In Jaw	8 (.79%)
Syncope	8 (.79%)
Heart Rate Decreased	7 (.69%)
Hyperhidrosis	7 (.69%)
Insomnia	7 (.69%)
Post Procedural Complication	7 (.69%)
Ventricular Fibrillation	7 (.69%)
Anxiety	6 (.59%)
Atrial Fibrillation	6 (.59%)
Bradycardia	6 (.59%)
Drug Hypersensitivity	6 (.59%)
Electrocardiogram St Segment Elevat...	6 (.59%)
Facial Pain	6 (.59%)
Flushing	6 (.59%)
Supraventricular Tachycardia	6 (.59%)
Unresponsive To Stimuli	6 (.59%)
Ventricular Tachycardia	6 (.59%)
Angina Pectoris	5 (.49%)
Asthenia	5 (.49%)
Coronary Artery Stenosis	5 (.49%)
Electrocardiogram St Segment Depres...	5 (.49%)
Feeling Cold	5 (.49%)
Haemoptysis	5 (.49%)
Hypoaesthesia	5 (.49%)
Lacrimation Increased	5 (.49%)
Nervousness	5 (.49%)
Panic Reaction	5 (.49%)
Poor Quality Drug Administered	5 (.49%)
Respiratory Distress	5 (.49%)
Respiratory Failure	5 (.49%)
Sepsis	5 (.49%)
Shock	5 (.49%)
Tachycardia	5 (.49%)
Aura	4 (.4%)
Bacterial Culture Positive	4 (.4%)
Disorientation	4 (.4%)
Dysphagia	4 (.4%)
Escherichia Infection	4 (.4%)
Feeling Abnormal	4 (.4%)
Heart Rate Increased	4 (.4%)
Malaise	4 (.4%)
Migraine	4 (.4%)
Myocardial Ischaemia	4 (.4%)
Nervous System Disorder	4 (.4%)
Neurological Symptom	4 (.4%)
Neuropathy Peripheral	4 (.4%)
Nodal Rhythm	4 (.4%)
Palpitations	4 (.4%)
Pharyngeal Oedema	4 (.4%)
Septic Shock	4 (.4%)
Acute Respiratory Failure	3 (.3%)
Anaphylactic Reaction	3 (.3%)
Atrioventricular Block First Degree	3 (.3%)
Blood Pressure Immeasurable	3 (.3%)
Cardiac Failure	3 (.3%)
Cyanosis	3 (.3%)
Drug Ineffective	3 (.3%)
Drug Interaction	3 (.3%)
Electrocardiogram Abnormal	3 (.3%)
Electrocardiogram Change	3 (.3%)
Electrocardiogram T Wave Inversion	3 (.3%)
Enterobacter Infection	3 (.3%)
Enterobacter Sepsis	3 (.3%)
Fatigue	3 (.3%)
Groin Pain	3 (.3%)
Heart Rate Irregular	3 (.3%)
Hypersensitivity	3 (.3%)
Ischaemia	3 (.3%)
Left Ventricular Failure	3 (.3%)
Medication Error	3 (.3%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Adenoscan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Adenoscan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Adenoscan

What are the most common Adenoscan adverse events reported to the FDA?

Cardiac Arrhythmias	120 (11.86%)
Respiratory	100 (9.88%)
Cardiac And Vascular Investigations	82 (8.1%)
Neurological	68 (6.72%)
Coronary Artery	44 (4.35%)
Gastrointestinal Signs	44 (4.35%)
Procedural And Device Related Injur...	22 (2.17%)
Decreased And Nonspecific Blood Pre...	21 (2.08%)
Movement Disorders	21 (2.08%)
Administration Site Reactions	19 (1.88%)
Bronchial Disorders	19 (1.88%)
	Show More
Anxiety Disorders	18 (1.78%)
Headaches	18 (1.78%)
Infections - Pathogen Unspecified	18 (1.78%)
Physical Examination Topics	16 (1.58%)
Gastrointestinal Motility And Defec...	15 (1.48%)
Metabolic, Nutritional And Blood Ga...	14 (1.38%)
Musculoskeletal And Connective Tiss...	14 (1.38%)
Allergic Conditions	13 (1.28%)
Bacterial Infectious	12 (1.19%)
Lower Respiratory Tract Disorders	12 (1.19%)
Seizures	12 (1.19%)
Medication Errors	11 (1.09%)
Therapeutic And Nontherapeutic Effe...	11 (1.09%)
Body Temperature Conditions	10 (.99%)
Bone Disorders	9 (.89%)
Heart Failures	9 (.89%)
Upper Respiratory Tract Disorders	9 (.89%)
Vascular Hypertensive	9 (.89%)
Cardiac Disorder Signs	8 (.79%)
Skin Appendage Conditions	8 (.79%)
Sleep Disorders	8 (.79%)
Muscle	7 (.69%)
Vascular	7 (.69%)
Deliria	6 (.59%)
Eye	6 (.59%)
Microbiology And Serology	6 (.59%)
Viral Infectious	5 (.49%)
Epidermal And Dermal Conditions	4 (.4%)
Glucose Metabolism Disorders	4 (.4%)
Joint	4 (.4%)
Peripheral Neuropathies	4 (.4%)
Renal Disorders	4 (.4%)
Arteriosclerosis, Stenosis, Vascula...	3 (.3%)
Communication Disorders	3 (.3%)
Injuries	3 (.3%)
Mental Impairment	3 (.3%)
Neurological, Special Senses And Ps...	3 (.3%)
Water, Electrolyte And Mineral	3 (.3%)
White Blood Cell	3 (.3%)
Angiedema And Urticaria	2 (.2%)
Central Nervous System Vascular	2 (.2%)
Cranial Nerve Disorders	2 (.2%)
Lipid Metabolism	2 (.2%)
Mood Disorders	2 (.2%)
Myocardial	2 (.2%)
Acid-base	1 (.1%)
Anemias Nonhemolytic And Marrow Dep...	1 (.1%)
Appetite And General Nutritional	1 (.1%)
Bile Duct	1 (.1%)
Bone And Joint Injuries	1 (.1%)
Changes In Physical Activity	1 (.1%)
Depressed Mood Disorders	1 (.1%)
Eating Disorders	1 (.1%)
Electrolyte And Fluid Balance Condi...	1 (.1%)
Enzyme	1 (.1%)
Fatal Outcomes	1 (.1%)
Hematological And Lymphoid Tissue T...	1 (.1%)
Lifestyle Issues	1 (.1%)
Product Quality Issues	1 (.1%)
Pulmonary Vascular	1 (.1%)
Respiratory Tract Therapeutic Proce...	1 (.1%)
Retina, Choroid And Vitreous Hemorr...	1 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Adenoscan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Adenoscan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.